COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > probability > Liouville Brownian motion and thick points of the Gaussian free field
Liouville Brownian motion and thick points of the Gaussian free fieldAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact John Shimmon. This talk has been canceled/deleted We find a lower bound for the Hausdorff dimension that a Liouville Brownian motion spends in alpha-thick points of the Gaussian Free Field, where Alpha is not necessarily equal to the parameter used in the construction of the geometry. This completes a conjecture by N. Berestycki, where the corresponding upper bound was shown. In the course of the proof, we obtain estimates on the (Euclidean) diffusivity exponent, which depends strongly on the nature of the starting point. For a Liouville typical point, it is 1/(1-gamma^2/2). In particular, for gamma > sqrt(2). the path is Lebesgue-almost everywhere differentiable, almost surely. This provides a detailed description of the multifractal nature of Liouville Brownian motion. This talk is part of the probability series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsHEP phenomenology joint Cavendish-DAMTP seminar Cambridge International Development Conference 2015 Scott Polar Research Institute - Polar Physical Sciences Seminar Type the title of a new list here Homerton CIG Series 2015 - 2016 12th Annual Disability LectureOther talksDownstream dispersion of bedload tracers HONORARY FELLOWS PRIZE LECTURE - Towards a silent aircraft Number, probability and community: the Duckworth-Lewis-Stern data model, Monte Carlo simulations and counterfactual futures in cricket Women's Staff Network: Career Conversations Immigration policy-making beyond 'Western liberal democracies' Investigation into appropriate statistical models for the analysis and visualisation of data captured in clinical trials using wearable sensors |